Kura Oncology Inc (KURA) stock news · rev $67.5M
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
This KURA news page leads with what Kura Oncology Inc filed — not a scraped headline mill.
No cached 8-K sentence for KURA yet. We will not pad this page with generic market recap.
Latest reported KURA revenue for 2025-12-31 was $67.5M. Net income was -$278.7M. Revenue was up 25.2% from 2024-12-31 to 2025-12-31. KURA currently screens at market cap $861.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the KURA stock page; for the tape open the quote page.
KURA stock news FAQ
What are KURA's latest revenue and net income?
Latest cached Kura Oncology Inc (KURA) revenue for Dec 31, 2025 was $67.5M. Net income was -$278.7M. Statements: https://lician.com/financials/kura
How did KURA revenue change from the prior cached period?
Cached Kura Oncology Inc (KURA) revenue was up 25.2% from $53.9M (Dec 31, 2024) to $67.5M (Dec 31, 2025). Statements: https://lician.com/financials/kura
What is KURA's market cap?
Kura Oncology Inc (KURA) market cap is $861.1M on the latest cached fundamentals snapshot.
What kind of company is KURA?
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
Where is KURA stock news listed?
Cached stock news for Kura Oncology Inc (KURA) is listed at https://lician.com/news/kura. Filings: https://lician.com/sec/kura
Not investment advice.